National Medical Products Administration: By 2025, 475 Chinese medicinal materials production bases will pass inspection.

Today, reporters learned from the National Traditional Chinese Medicine Registration Management and Quality Safety Supervision Work Conference in 2026 that by the end of 2025, 475 traditional Chinese medicine production bases nationwide had passed extended inspections, with a planting area of nearly 1.24 million mu, providing 101 types of traditional Chinese medicinal materials for 215 traditional Chinese medicine production enterprises to produce 275 varieties. The National Medical Products Administration stated that in 2025, regulatory authorities focused on early warning of risks in traditional Chinese medicine, urging traditional Chinese medicine production enterprises to actively strengthen monitoring and early warning, take timely measures to effectively control risks, and eliminate hidden dangers. Improve the safety information of traditional Chinese medicine instructions, issue the "Requirements for Writing Declaration Materials on Safety Information in Revised Drug Instructions for Traditional Chinese Medicines Already on the Market". Five batches of notices were issued, involving 666 approval numbers, and 21 related supplementary applications were completed.